Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study

Abstract

Low molecular weight heparin is acceptable to inpatients with advanced cancer receiving palliative care and has a positive impact on overall quality of life. Antiembolic stockings are an unacceptable intervention in this patient group. Guidelines on thromboprophylaxis are urgently needed for palliative care inpatient units and hospices.